Blog - INTERNET MÉDICA

■ Novel coronavírus disease (COVID-19) and biologic therapy for psoriasis: sucessful recovery in two patients after infection with severe acute respiratory syndrome coronavírus 2 (SARS-CoV-2)

Nicholas D. Brownstone, Quinn G. Thibodeaux, Vidhatha D. Reddy et al

Dermatol Ther (Heidelb) 2020 Aug; 10(4): 881–885

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255969/

■ Novel coronavírus disease (COVID-19) and biologic therapy for psoriasis: infection risk and patient counseling in uncertain times

Nicholas D. Brownstone, Quinn G. Thibodeaux, Vidhatha D. Reddy, et al

Dermatol Ther (Heidelb) 2020 Jun; 10(3): 339–349

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160052/

■ Psoriasis, biological drugs and coronavírus disease 2019: real life experience of two Italian provinces

Martina Vispi, Teresa Corradin, Camilla Peccianti, et al

Dermatol Reports. 2020 Jun 25; 12(1): 8642

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336268/

■ Unexpected presentation of COVID-19 in a 38-old male patient: a case report

Narges Malih, Ghazal Hajinasrollah, Marjan Zare, Mahboobeh Taheri

Case Rep Dermatol. 2020 May-Aug; 12(2): 124–131

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443664/

■ Dermatological aspects of SARS-CoV-2 infection: mechanisms and manifestations

Myriam Garduño-Soto, Jose Alberto Choreño-Parra, Jorge Cazarin-Barrientos

Arch Dermatol Res. 2020 Nov 6 : 1–12.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646711/

■ Are the cutaneous manifestationns during or due to SARS-CoV-2 infection/,COVID-19 frequent or not? Revisionn of possible pathophysiologic mechanisms

Paulo Ricardo Criado, Beatrice Martinez Zugaib Abdalla et al

Inflamm Res. 2020 Jun 2 : 1–12

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7266387/

■ National Psoriasis Foundation COVID-19 Task Force Guidance for management of psoriatic disease during the pandemic: versionn 1

Joel M. Gelfand, April W. Armstrong, Stacie Bell, et al

J Am Acad Dermatol. 2020 Dec; 83(6): 1704–1716

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471802/

■ COVID-19 pandemic and the skin

Kossara Drenovska, Enno Schmidt, Snejina Vassileva

Int J Dermatol. 2020 Sep 21 : 10.1111/ijd.15189

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537512/

■ A review of the dematological manifestationns of coronarvirus disease 2019 (COVID-19)

Farah Marraha, Ibtissam Al Faker, Salim Gallouj

Dermatol Res Pract. 2020; 2020: 936047

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422480/

■ Dr Paulo Fernando Leite

Cardiologia/Prevenção Cardiovascular

Estratificação de Risco Cardiovascular

Consultório: Rua Padre Rolim 815/sala 601

Tel: 33245518

CRMMG: 7026

Email: pfleite1873@gmail.com

Data: dezembro 2020

Rosácea Online (Rosacea)

Por Paulo Leite 14/12/2020

■ Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea Consensus 2019 panel

Schaller, L.M.C. Almeida, A. Bewley, B. Cribier, et al

Br J Dermatol. 2020 May; 182(5): 1269–1276

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317217/

■ Rosacea treatment guideline for the Netherlands

E.J. van Zuuren, M.M.D. van der Linden, B.W.M. Arents

Br J Dermatol. 2020 Jun; 182(6): 1504–1506

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317907/

■ Rosacea: diagnosis and treatment

L K Oge, H L Muncie, A R Phillips-Savoy

Am Fam Physician 2015, vol 92 (3): 187-196

https://www.aafp.org/afp/2015/0801/p187.html

■ Rosacea and associated comorbidities: a google search trends analysis

Mark C. Marchitto, Anna L. Chien

J Clin Aesthet Dermatol. 2020 Jul; 13(7): 36–4

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492017/

■ Update on the management of rosacea from the American Acne & Rosacea Society

James Q. Del Rosso, Emil Tanghetti, Guy Webster et al

J Clin Aesthet Dermatol. 2020 Jun; 13(6 Suppl): 17–24

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710291/

■ Managing rosacea in the clinic: from pathophysiology to treatment – a review of the literature

Sandra Marchese Johnson, Andrew Berg, Chelsea Barr

J Clin Aesthet Dermatol. 2020 Apr; 13(4 Suppl): S17–S2

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384638/

■ Conventional and novel treatment modalities in rosacea

Burhan Engin, Defne Özkoca, Zekayi Kutlubay, Server Serdaroğlu

Clin Cosmet Investig Dermatol. 2020; 13: 179–186

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039055/

■ Demodex folliculorum infestations in common facial dermatoses: acne vulgaris, rosacea, seborrheic dermatitis,.

Aktaş Karabay, Ezgi and Aksu Çerman, Aslı

An. Bras. Dermatol., Mar 2020, vol.95, no.2, p.187-193

https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962020000200187&lng=en&nrm=iso

■ Dermoscopic monitoring of response to intense pulsed ligt in rosacea: a case report

Ajay Deshapande, Balachandra S. Ankad

Dermatol Pract Concept. 2020 Jul; 10(3): e2020058

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346587/

■ Microbiota in rosacea

Hei Sung Kim

Am J Clin Dermatol. 2020; 21(Suppl 1): 25–35

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584533/

■ Diversity and composition of the skin, blood and gut microbiome in rosacea – a systematic review of the literature

Klaudia Tutka, Magdalena Żychowska, Adam Reich

Microorganisms. 2020 Nov; 8(11): 1756

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695250/

■ Update on the management of rosacea from the American Acne & Rosacea Society

J Q Del Rosso, E Tanghetti, G Webster et al

J Clin Aesthet Dermatol 2019, vol 12 (6): 17-24

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624012/

■ Rosacea associated with increased risk of generalized anxiety disorder: a case-control study of prevalence and risk of anxiety in patients with rosácea

Incel Uysal, Pinar et al.

An. Bras. Dermatol., Nov 2019, vol.94, no.6, p.704-709

https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962019000600704&lng=en&nrm=iso

■ Rosacea: the patient experience is now ¨clear¨

M Schaller

EMJ Dermatol 2019; vol 7 (1): 52-59

https://www.emjreviews.com/rosacea-the-patient-experience-is-now-clear/

■ The pathogenic role of Demodex Mites in rosacea: a potential therapeutic target already in erythematotelangiectatic rosacea?

Fabienne M. N. Forton

Dermatol Ther (Heidelb) 2020 Dec; 10(6): 1229–1253

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649190/

■ Clinical picture, diagnosis and treatment of rosacea, complicated by Demodex mites

Alexey Kubanov, Yuliya Gallyamova, Anzhela Kravchenko

Dermatol Reports. 2019 Jan 23; 11(1): 7675

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452096/

■ Rosacea is characterized by a profoundly diminished skin barrier

B Medgyesi, Z Dajnoki, G Béke et al

Journal of Investigative Dermatology 2020, vol 140 (10)

https://www.jidonline.org/article/S0022-202X(20)31198-2/fulltext

■ Systemic steroids, clarithromycin and metronidazole in the treatment of rosacea during pregnancy

B M Clanner-Engleshofen, H Schwaiger, G Plewig et al

J Clin Case Rep 2018, vol 8: 4

https://www.hilarispublisher.com/open-access/systemic-steroids-clarithromycin-and-metronidazole-in-the-trea-tmentof-rosacea-during-pregnancy-2165-7920-10001100.pdf

■ A multicentre, randomized, double-masked, parallel group, vehicle-controlled phase IIb study to evaluate the safety and efficacy of 1% and 3% topical minocycline gel in patients with papulostular rosacea